Cargando…

Synthesis, Cytotoxic, and Computational Screening of Some Novel Indole–1,2,4-Triazole-Based S-Alkylated N-Aryl Acetamides

Molecular hybridization has emerged as the prime and most significant approach for the development of novel anticancer chemotherapeutic agents for combating cancer. In this pursuit, a novel series of indole–1,2,4-triazol-based N-phenyl acetamide structural motifs 8a–f were synthesized and screened a...

Descripción completa

Detalles Bibliográficos
Autores principales: Zahoor, Ameer Fawad, Saeed, Sadaf, Rasul, Azhar, Noreen, Razia, Irfan, Ali, Ahmad, Sajjad, Faisal, Shah, Al-Hussain, Sami A., Saeed, Muhammad Athar, Muhammed, Muhammed Tilahun, Muhammad, Zeinab A., Zaki, Magdi E. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669176/
https://www.ncbi.nlm.nih.gov/pubmed/38002078
http://dx.doi.org/10.3390/biomedicines11113078
_version_ 1785149212491513856
author Zahoor, Ameer Fawad
Saeed, Sadaf
Rasul, Azhar
Noreen, Razia
Irfan, Ali
Ahmad, Sajjad
Faisal, Shah
Al-Hussain, Sami A.
Saeed, Muhammad Athar
Muhammed, Muhammed Tilahun
Muhammad, Zeinab A.
Zaki, Magdi E. A.
author_facet Zahoor, Ameer Fawad
Saeed, Sadaf
Rasul, Azhar
Noreen, Razia
Irfan, Ali
Ahmad, Sajjad
Faisal, Shah
Al-Hussain, Sami A.
Saeed, Muhammad Athar
Muhammed, Muhammed Tilahun
Muhammad, Zeinab A.
Zaki, Magdi E. A.
author_sort Zahoor, Ameer Fawad
collection PubMed
description Molecular hybridization has emerged as the prime and most significant approach for the development of novel anticancer chemotherapeutic agents for combating cancer. In this pursuit, a novel series of indole–1,2,4-triazol-based N-phenyl acetamide structural motifs 8a–f were synthesized and screened against the in vitro hepatocellular cancer Hep-G2 cell line. The MTT assay was applied to determine the anti-proliferative potential of novel indole–triazole compounds 8a–f, which displayed cytotoxicity potential as cell viabilities at 100 µg/mL concentration, by using ellipticine and doxorubicin as standard reference drugs. The remarkable prominent bioactive structural hybrids 8a, 8c, and 8f demonstrated good-to-excellent anti-Hep-G2 cancer chemotherapeutic potential, with a cell viability of (11.72 ± 0.53), (18.92 ± 1.48), and (12.93 ± 0.55), respectively. The excellent cytotoxicity efficacy against the liver cancer cell line Hep-G2 was displayed by the 3,4-dichloro moiety containing indole–triazole scaffold 8b, which had the lowest cell viability (10.99 ± 0.59) compared with the standard drug ellipticine (cell viability = 11.5 ± 0.55) but displayed comparable potency in comparison with the standard drug doxorubicin (cell viability = 10.8 ± 0.41). The structure–activity relationship (SAR) of indole–triazoles 8a–f revealed that the 3,4-dichlorophenyl-based indole–triazole structural hybrid 8b displayed excellent anti-Hep-G2 cancer chemotherapeutic efficacy. The in silico approaches such as molecular docking scores, molecular dynamic simulation stability data, DFT, ADMET studies, and in vitro pharmacological profile clearly indicated that indole–triazole scaffold 8b could be the lead anti-Hep-G2 liver cancer therapeutic agent and a promising anti-Hep-G2 drug candidate for further clinical evaluations.
format Online
Article
Text
id pubmed-10669176
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-106691762023-11-16 Synthesis, Cytotoxic, and Computational Screening of Some Novel Indole–1,2,4-Triazole-Based S-Alkylated N-Aryl Acetamides Zahoor, Ameer Fawad Saeed, Sadaf Rasul, Azhar Noreen, Razia Irfan, Ali Ahmad, Sajjad Faisal, Shah Al-Hussain, Sami A. Saeed, Muhammad Athar Muhammed, Muhammed Tilahun Muhammad, Zeinab A. Zaki, Magdi E. A. Biomedicines Article Molecular hybridization has emerged as the prime and most significant approach for the development of novel anticancer chemotherapeutic agents for combating cancer. In this pursuit, a novel series of indole–1,2,4-triazol-based N-phenyl acetamide structural motifs 8a–f were synthesized and screened against the in vitro hepatocellular cancer Hep-G2 cell line. The MTT assay was applied to determine the anti-proliferative potential of novel indole–triazole compounds 8a–f, which displayed cytotoxicity potential as cell viabilities at 100 µg/mL concentration, by using ellipticine and doxorubicin as standard reference drugs. The remarkable prominent bioactive structural hybrids 8a, 8c, and 8f demonstrated good-to-excellent anti-Hep-G2 cancer chemotherapeutic potential, with a cell viability of (11.72 ± 0.53), (18.92 ± 1.48), and (12.93 ± 0.55), respectively. The excellent cytotoxicity efficacy against the liver cancer cell line Hep-G2 was displayed by the 3,4-dichloro moiety containing indole–triazole scaffold 8b, which had the lowest cell viability (10.99 ± 0.59) compared with the standard drug ellipticine (cell viability = 11.5 ± 0.55) but displayed comparable potency in comparison with the standard drug doxorubicin (cell viability = 10.8 ± 0.41). The structure–activity relationship (SAR) of indole–triazoles 8a–f revealed that the 3,4-dichlorophenyl-based indole–triazole structural hybrid 8b displayed excellent anti-Hep-G2 cancer chemotherapeutic efficacy. The in silico approaches such as molecular docking scores, molecular dynamic simulation stability data, DFT, ADMET studies, and in vitro pharmacological profile clearly indicated that indole–triazole scaffold 8b could be the lead anti-Hep-G2 liver cancer therapeutic agent and a promising anti-Hep-G2 drug candidate for further clinical evaluations. MDPI 2023-11-16 /pmc/articles/PMC10669176/ /pubmed/38002078 http://dx.doi.org/10.3390/biomedicines11113078 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Zahoor, Ameer Fawad
Saeed, Sadaf
Rasul, Azhar
Noreen, Razia
Irfan, Ali
Ahmad, Sajjad
Faisal, Shah
Al-Hussain, Sami A.
Saeed, Muhammad Athar
Muhammed, Muhammed Tilahun
Muhammad, Zeinab A.
Zaki, Magdi E. A.
Synthesis, Cytotoxic, and Computational Screening of Some Novel Indole–1,2,4-Triazole-Based S-Alkylated N-Aryl Acetamides
title Synthesis, Cytotoxic, and Computational Screening of Some Novel Indole–1,2,4-Triazole-Based S-Alkylated N-Aryl Acetamides
title_full Synthesis, Cytotoxic, and Computational Screening of Some Novel Indole–1,2,4-Triazole-Based S-Alkylated N-Aryl Acetamides
title_fullStr Synthesis, Cytotoxic, and Computational Screening of Some Novel Indole–1,2,4-Triazole-Based S-Alkylated N-Aryl Acetamides
title_full_unstemmed Synthesis, Cytotoxic, and Computational Screening of Some Novel Indole–1,2,4-Triazole-Based S-Alkylated N-Aryl Acetamides
title_short Synthesis, Cytotoxic, and Computational Screening of Some Novel Indole–1,2,4-Triazole-Based S-Alkylated N-Aryl Acetamides
title_sort synthesis, cytotoxic, and computational screening of some novel indole–1,2,4-triazole-based s-alkylated n-aryl acetamides
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669176/
https://www.ncbi.nlm.nih.gov/pubmed/38002078
http://dx.doi.org/10.3390/biomedicines11113078
work_keys_str_mv AT zahoorameerfawad synthesiscytotoxicandcomputationalscreeningofsomenovelindole124triazolebasedsalkylatednarylacetamides
AT saeedsadaf synthesiscytotoxicandcomputationalscreeningofsomenovelindole124triazolebasedsalkylatednarylacetamides
AT rasulazhar synthesiscytotoxicandcomputationalscreeningofsomenovelindole124triazolebasedsalkylatednarylacetamides
AT noreenrazia synthesiscytotoxicandcomputationalscreeningofsomenovelindole124triazolebasedsalkylatednarylacetamides
AT irfanali synthesiscytotoxicandcomputationalscreeningofsomenovelindole124triazolebasedsalkylatednarylacetamides
AT ahmadsajjad synthesiscytotoxicandcomputationalscreeningofsomenovelindole124triazolebasedsalkylatednarylacetamides
AT faisalshah synthesiscytotoxicandcomputationalscreeningofsomenovelindole124triazolebasedsalkylatednarylacetamides
AT alhussainsamia synthesiscytotoxicandcomputationalscreeningofsomenovelindole124triazolebasedsalkylatednarylacetamides
AT saeedmuhammadathar synthesiscytotoxicandcomputationalscreeningofsomenovelindole124triazolebasedsalkylatednarylacetamides
AT muhammedmuhammedtilahun synthesiscytotoxicandcomputationalscreeningofsomenovelindole124triazolebasedsalkylatednarylacetamides
AT muhammadzeinaba synthesiscytotoxicandcomputationalscreeningofsomenovelindole124triazolebasedsalkylatednarylacetamides
AT zakimagdiea synthesiscytotoxicandcomputationalscreeningofsomenovelindole124triazolebasedsalkylatednarylacetamides